健保藥品HTA評估報告
| 序號 | 標題 | 檔案類型 |
|---|---|---|
| 141 | 擴增Mepolizumab 成分藥品(如Nucala)給付範圍 |
|
| 142 | 采視明(EYLEA® Injection) |
|
| 143 | 妥復克膜衣錠(Giotrif® Film-coated Tablets) |
|
| 144 | 傲迪適眼後房植入劑(Ozurdex) |
|
| 145 | 截剋瘤膠囊 250毫克/200毫克(Xalkori Capsules 250mg/200mg) |
|
| 146 | 日沛樂膜衣錠240毫克(Zelboraf) |
|
| 147 | 抑癌特膜衣錠 (Inlyta Film-Coated Tablets 1mg及5mg) |
|
| 148 | 得喜胃通緩釋膠囊 (Dexilant Delayed Release Capsules 30mg及60mg) |
|
| 149 | 泰嘉錠250毫克膜衣錠 (Tykerb Tablets 250mg) |
|
| 150 | 迪開舒膜衣錠500微克 (Daxas Film-Coated Tablets 500mcg) |
|